NovaBridge Biosciences: eps_diluted
| Value | {"per": "shares", "amount": 0.05, "concept": "us-gaap:EarningsPerShareDiluted", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-06-30 |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7b8d5d9e-efba-4b9f-9204-326081fb13f1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-25-230890Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/eps-diluted/2024-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7b8d5d9e-efba-4b9f-9204-326081fb13f1
History
- no predecessors — first report